GURUFOCUS.COM » STOCK LIST » Creative Antibiotics AB (OSTO:CAS) » Definitions » Return-on-Tangible-Asset

Creative Antibiotics AB (OSTO:CAS) Return-on-Tangible-Asset : -90.59% (As of Mar. 2013)


View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Creative Antibiotics AB's annualized Net Income for the quarter that ended in Mar. 2013 was kr-11.52 Mil. Creative Antibiotics AB's average total tangible assets for the quarter that ended in Mar. 2013 was kr12.72 Mil. Therefore, Creative Antibiotics AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2013 was -90.59%.

The historical rank and industry rank for Creative Antibiotics AB's Return-on-Tangible-Asset or its related term are showing as below:

OSTO:CAS's Return-on-Tangible-Asset is not ranked *
in the industry.
Industry Median:
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Creative Antibiotics AB Return-on-Tangible-Asset Historical Data

The historical data trend for Creative Antibiotics AB's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Return-on-Tangible-Asset Chart

Creative Antibiotics AB Annual Data
Trend Jun08 Jun09 Jun10 Dec11
Return-on-Tangible-Asset
-27.53 -51.56 -38.14 -35.04

Creative Antibiotics AB Quarterly Data
Jun08 Mar09 Jun09 Sep09 Dec09 Mar10 Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Mar13
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.63 -74.41 -102.15 -59.63 -90.59

Competitive Comparison of Creative Antibiotics AB's Return-on-Tangible-Asset

For the subindustry, Creative Antibiotics AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Antibiotics AB's Return-on-Tangible-Asset Distribution in the Industry

For the industry and sector, Creative Antibiotics AB's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Creative Antibiotics AB's Return-on-Tangible-Asset falls into.



Creative Antibiotics AB Return-on-Tangible-Asset Calculation

Creative Antibiotics AB's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2011 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2011 )  (A: Jun. 2010 )(A: Dec. 2011 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2011 )  (A: Jun. 2010 )(A: Dec. 2011 )
=-12.983/( (44.96+29.151)/ 2 )
=-12.983/37.0555
=-35.04 %

Creative Antibiotics AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2013 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2013 )  (Q: Sep. 2012 )(Q: Mar. 2013 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2013 )  (Q: Sep. 2012 )(Q: Mar. 2013 )
=-11.524/( (15.535+9.908)/ 2 )
=-11.524/12.7215
=-90.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2013) net income data.


Creative Antibiotics AB  (OSTO:CAS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Creative Antibiotics AB Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Antibiotics AB (OSTO:CAS) Business Description

Traded in Other Exchanges
N/A
Address
Website

Creative Antibiotics AB (OSTO:CAS) Headlines

From GuruFocus

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-28-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-18-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-27-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-07-2022

Cascade Acquisition Corp (CAS.U) CEO Jay N. Levine Bought $2.5 million of Shares

By GuruFocus Research GuruFocus Editor 11-27-2020

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 07-07-2022

Cascade Acquisition Corp. Announces Liquidation

By GlobeNewswire GlobeNewswire 05-18-2022